Why ZANTAC 150* (Ranitidine hydrochloride ) is Prescribed for Patients*
Patient opinion of ZANTAC 150: somewhat satisfied (average rating score: 2.72)
(based on 176 reviews - combined drugs with same active ingredient - see footnote for timeframe )Top 10 Reasons for taking** ZANTAC 150
(reported on Ask a Patient)
Reason | # of Ask a Patient Reviews | |
---|---|---|
1 | Gastrooesophageal reflux disease* | 28 |
2 | Dyspepsia* | 16 |
3 | Gastritis* | 7 |
4 | Ulcer | 4 |
5 | Abdominal pain upper | 1 |
6 | Hypersensitivity | 1 |
7 | Oesophagitis | 1 |
8 | Urticaria | 1 |
9 | Urticaria cholinergic | 1 |
*Also included as reason for taking drug in FDA Adverse Events summary.
Top 20 Side Effects of ZANTAC 150 **
(reported on Ask a Patient)
Side Effect | # of Ask a Patient Reviews | |
---|---|---|
1 | Headache* | 36 |
2 | Anxiety | 28 |
3 | Nausea* | 23 |
4 | Insomnia | 22 |
5 | Constipation | 17 |
6 | Flatulence | 16 |
7 | Dizziness* | 15 |
8 | Pain* | 13 |
9 | Discomfort | 13 |
10 | Dyspepsia | 12 |
11 | Myalgia | 11 |
12 | Abdominal discomfort | 11 |
13 | Chest pain | 9 |
14 | Abdominal distension | 9 |
15 | Eructation | 8 |
16 | Somnolence | 8 |
17 | Cardiac flutter | 8 |
18 | Vision blurred | 8 |
19 | Oropharyngeal pain | 7 |
20 | Malaise | 7 |
*Important! This side effect is also associated with Adverse Event Reports (serious reaction); Also see charts in FDA Adverse Events summary.
Please click here for Safety Information and FDA Adverse Events summary for ZANTAC 150
* Reviews for drugs with the same active ingredients have been aggregated in this analysis: Ranitidine hydrochloride (Zantac 25, Wal zan 150, Equate acid reducer, Careone acid reducer, Acid relief, Formucare ranitidine, Leader acid control, Major ranitidine, Ranitidina, Wal zan 75, Wal zan acid reducer, Acid reducer 150, Aptidine, Up and up ranitidine, Equate ranitidine, Ranitidine 150, Wal-zan 75, Zantac 75, Wal-zan, Ranitidine 75, Zantac 300, Ranitidine, Zantac, Zantac 150)
**Historical Analytics (through 2015) of AskaPatient Reviews Provided by Druginformer.com